TheraRadar
← Back
Data updated: Mar 29, 2026

SHANDONG NEW TIME PHARMACEUTICAL CO LTD

OncologyMetabolicCardiovascular
Pharma

SHANDONG NEW TIME PHARMACEUTICAL CO LTD is a pharmaceutical company focused on Oncology, Metabolic, Cardiovascular.

-
Since
0
Drugs
-
Trials
0
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

No recent activity
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Oncology 45%
0 drugs Phase 2: 4 Phase 1: 2
Metabolic 18%
0 drugs Phase 3: 1
Cardiovascular 18%
0 drugs Phase 3: 1
Gastroenterology 18%
0 drugs Phase 2: 2

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Merck big-pharma
Oncology, Cardiovascular, Metabolic
Johnson & Johnson big-pharma
Oncology, Cardiovascular, Metabolic
Bayer big-pharma
Oncology, Cardiovascular, Metabolic
AstraZeneca big-pharma
Oncology, Cardiovascular, Metabolic
Takeda big-pharma
Oncology, Gastroenterology, Metabolic